4//SEC Filing
Sumner Michael John 4
Accession 0001055726-24-000042
CIK 0001055726other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 5:02 PM ET
Size
7.6 KB
Accession
0001055726-24-000042
Insider Transaction Report
Form 4
Sumner Michael John
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2024-06-30+2,917→ 8,219 total - Exercise/Conversion
Restricted Stock Unit
2024-06-30−2,917→ 2,916 total→ Common Stock (2,917 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 8,749 restricted stock units is as follows: 2,916 shares vested on June 30, 2023; 2,917 shares vested on June 30, 2024; and 2,916 shares will vest on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- [F2]Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001936799
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 5:02 PM ET
- Size
- 7.6 KB